Yahoo
NasdaqGS - BOATS Real Time Price USD

Recursion Pharmaceuticals, Inc. (RXRX)

3.8050 +0.2850 (+8.10%)
At close: November 9 at 4:00:00 PM EST
3.7200 -0.0850 (-2.23%)
Overnight: 8:43:23 PM EST
Trade RXRX on Coinbase

News headlines

Updated 47m ago
Powered by Yahoo Scout

Recursion Pharmaceuticals reported Q3 2026 revenue of $18.6 million, a $119 million net loss, and clinical progress for REC-4881 and REC-1245. The company also raised financing, extending its projected cash runway into 2029, while shares gained 8.24% on November 9based on the regular session plus after-hours trading. The main debate remains whether clinical advances and partnerships can offset ongoing losses and dilution risk.

Mobilize your Website
View Site in Mobile | Classic
Share by: